Will Pipeline Disasters Devour Eli Lilly & Co. (LLY) Stock?
Eli Lilly & Co. (NYSE:LLY) investors just can't catch a break lately.
Incyte Corp (INCY)
Market is closed
News
- First
- << Previous
- 101 - 110
Infinity Pharmaceuticals Inc. (INFI): Watch This Data
Infinity Pharmaceuticals Inc. (NASDAQ:INFI) was in 22 hedge funds' portfolio at the end of December. INFI has experienced an increase in enthusiasm from smart money of late.
Pfizer Inc. (PFE): Risks, Hesitations & Key Opportunities
Take a look around the pharmaceutical industry and you won't find many companies with market caps exceeding $100 billion (seven by my count).
Momenta Pharmaceuticals, Inc. (MNTA), Incyte Corporation (INCY), Solazyme Inc (SZYM): Three Biotech Companies for Young Investors
Take one look at the returns from biotech darlings Celgene Corporation (NASDAQ:CELG), Biogen Idec Inc. (NASDAQ:BIIB), and Gilead Sciences, Inc. (NASDAQ:GILD) over the past year.
Theravance Inc (THRX): Here's One Thing To Know About The Stock Today
Theravance Inc (NASDAQ:THRX) has experienced a decrease in support from the world's most elite money managers of late, but insiders on the whole appear bullish.
Pharmacyclics, Inc. (PCYC), Genomic Health, Inc. (GHDX)...Mega-Hedge Fund Focusing on The Life Sciences
The $3+ billion Baker Brothers Advisors equity portfolio, managed by brothers Julian and Felix Baker, focuses almost exclusively on life science companies with a small to medium sized market capitalization...
Do Hedge Funds and Insiders Love Incyte Corporation (NASDAQ:INCY)?
Incyte Corporation (NASDAQ:INCY) was in 15 hedge funds' portfolio at the end of the fourth quarter of 2012.
Why Cyprus Won't Hold Back the Dow: JPMorgan Chase & Co. (JPM), Bank of America Corp (BAC), Incyte Corporation (INCY)
With the stock market near record highs, investors are on edge, and the slightest hint of trouble can cause near-panic.
Can Myriad Genetics, Inc. (MYGN) Survive the Supreme Court?
The market has been less than thrilled about an upcoming Supreme Court decision on the legality of the best-selling analytical test of Myriad Genetics, Inc. (NASDAQ:MYGN) .
Is Gilead Sciences, Inc. (GILD) Destined for Greatness?
Every investor can appreciate a stock that consistently beats the Street without getting ahead of its fundamentals and risking a meltdown.
- First
- << Previous
- 101 - 110
Billionaire Hedge Funds
